My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

VistaShares Target 15 USA Quality Income ETF (NY:QUSA)

18.29 +0.03 (+0.19%)

Streaming Delayed Price Updated: 1:06 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VistaShares Target 15 USA Quality Income ETF

Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics ↗

December 18, 2025

Lilly’s Orforglipron is eligible for a fast-track review by the FDA in treating obesity.

Via Stocktwits

Lam Research Stock Saw A Price Target Hike From B. Riley – What’s The Driving Factor? ↗

December 18, 2025

B. Riley raised its price target on Lam Research to $195 from $180.

Via Stocktwits

Topics Artificial Intelligence

Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report ↗

December 17, 2025

While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide decanoate, the other is its cancer therapy Sacituzumab tirumotecan.

Via Stocktwits

Oracle Denies Data Center Delay Report After Shares Slide On OpenAI Build-Out Concerns ↗

December 12, 2025

Oracle and OpenAI struck a $300 billion contract in September, with the former agreeing to build out data centers with a total capacity of 4.5 gigawatts.

Via Stocktwits

Topics Artificial Intelligence Earnings

Costco Stock Dips After Hours Despite Strong Q1 And Holiday Momentum — Retail Bulls Eye Rally Next Week ↗

December 11, 2025

The company reported adjusted earnings per share of $4.50, above an analyst estimate of $4.27, according to data from Fiscal AI.

Via Stocktwits

Topics Artificial Intelligence

Illinois Tool Works Tightens Profit Outlook As US Tariffs Stir Supply Concerns ↗

October 24, 2025

ITW (NYSE: ITW) shares down after reporting Q3 results and narrowing guidance. Revenue up 2.3%, operating margin improved.

Via Benzinga

Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside ↗

October 23, 2025

Morgan Stanley raised its price target on VKTX to $102 from $98 while maintaining an ‘Overweight’ rating.

Via Stocktwits

Topics Artificial Intelligence

Fastenal Profit Underwhelms Despite Higher Customer Spending ↗

October 13, 2025

Fastenal (NASDAQ: FAST) Q3 revenue beats estimates at $2.13B, but EPS misses by a cent; shares slide 4% premarket.

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.